Long-term follow-up of patients with multiple endocrine neoplasia type 1

Endocrine Journal

Volumn 54, Issue 2, 2007, Pages 295-302

  Sakurai, Akihiro ^a,b   Katai, Miyuki ^a   Yamashita, Koh ^a   Mori, Jun Ichiro ^a   Fukushima, Yoshimitsu ^b   Hashizume, Kiyoshi ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetes; MEN1; Pancreatectomy; Surgical indication; Tumor growth

Indexed keywords

INTERFERON; OCTREOTIDE; SOMATOSTATIN DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER MORTALITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MECHANISM; FEMALE; FOLLOW UP; GLUCOSE INTOLERANCE; HUMAN; HUMAN TISSUE; INSULIN RELEASE; LIVER METASTASIS; LIVER TUMOR; LONG TERM CARE; LYMPH NODE METASTASIS; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PANCREAS ISLET CELL TUMOR; PANCREAS RESECTION; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME;

ADENOMA, ISLET CELL; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEOPLASM METASTASIS; NEOPLASMS, SECOND PRIMARY; PANCREAS; PANCREATECTOMY; PANCREATIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34249062445     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K06-147     Document Type: Article

References (38)

1. Marx SJ, Stratakis CA (2005) Multiple endocrine neoplasia - Introduction. J Intern Med 257: 2-5.
2. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr, Marx SJ (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86: 5658-5671.
3. Majewski JT, Wilson SD (1979) The MEA-I syndrome: an all or none phenomenon? Surgery 86: 475-484.
4. Wilkinson S, Teh BT, Davey KR, McArdle JP, Young M, Shepherd JJ (1993) Cause of death in multiple endocrine neoplasia type 1. Arch Surg 128: 683-690.
5. Doherty GM, Olson JA, Frisella MM, Lairmore TC, Wells SA Jr, Norton JA (1998) Lethality of multiple endocrine neoplasia type I. World J Surg 22: 581-586.
6. Burgess JR, Greenaway TM, Parameswaran V, Challis DR, David R, Shepherd JJ (1998) Enteropancreatic malignancy associated with multiple endocrine neoplasia type 1: risk factors and pathogenesis. Cancer 83: 428-434.
7. Dean PG, van Heerden JA, Farley DR, Thompson GB, Grant CS, Harmsen WS, Ilstrup DM (2000) Are patients with multiple endocrine neoplasia type I prone to premature death? World J Surg 24: 1437-1441.
8. Gibril F, Venzon DJ, Ojeaburu JV, Bashir S, Jensen RT (2001) Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form. J Clin Endocrinol Metab 86: 5282-5293.
9. Bartsch DK, Langer P, Wild A, Schilling T, Celik I, Rothmund M, Nies C (2000) Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery 128: 958-966.
10. Lairmore TC, Chen VY, DeBenedetti MK, Gillanders WE, Norton JA, Doherty GM (2000) Duodenopancre atic resections in patients with multiple endocrine neoplasia type 1. Ann Surg 231: 909-918.
11. Hausman MS Jr, Thompson NW, Gauger PG, Doherty GM (2004) The surgical management of MEN-1 pancreatoduodenal neuroendocrine disease. Surgery 136: 1205-1211.
12. Thomas-Marques L, Murat A, Delemer B, Penfornis A, Cardot-Bauters C, Baudin E, Niccoli-Sire P, Levoir D, Choplin HB, Chabre O, Jovenin N, Cadiot G; Groupe des Tumeurs Endocrines (GTE) (2006) Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1. Am J Gastroenterol 101: 266-273.
13. Akerstrom G, Hessman O, Skogseid B (2002) Timing and extent of surgery in symptomatic and asymptomatic neuroendocrine tumors of the pancreas in MEN 1. Langenbecks Arch Surg 386: 558-569.
14. Wiedenmann B, Jensen RT, Mignon M, Modlin CI, Skogseid B, Doherty G, Oberg K (1998) Preoperative diagnosis and surgical management of neuroendocrine gastroenteropancreatic tumors: general recommendations by a consensus workshop. World J Surg 22: 309-318.
15. Madeira I, Terris B, Voss M, Denys A, Sauvanet A, Flejou JF, Vilgrain V, Belghiti J, Bernades P, Ruszniewski P (1998) Prognostic factors in patients with endocrine tumours of the duodenopancreatic area. Gut 43: 422-427.
16. Solorzano CC, Lee JE, Pisters PW, Vauthey JN, Ayers GD, Jean ME, Gagel RF, Ajani JA, Wolff RA, Evans DB (2001) Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. Surgery 130: 1078-1085.
17. Dralle H, Krohn SL, Karges W, Boehm BO, Brauckhoff M, Gimm O (2004) Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors. World J Surg 28: 1248-1260.
18. Kouvaraki MA, Solorzano CC, Shapiro SE, Yao JC, Perrier ND, Lee JE, Evans DB (2005) Surgical treatment of non-functioning pancreatic islet cell tumors. J Surg Oncol 89: 170-185.
19. Tomassetti P, Campana D, Piscitelli L, Casadei R, Santini D, Nori F, Morselli-Labate AM, Pezzelli R, Corinaldesi R (2005) Endocrine pancreatic tumors: factors correlated with survival. Ann Oncol 16: 1806-1810.
20. Cadiot G, Vuagnat A, Doukhan I, Murat A, Bonnaud G, Delemer B, Thiefin G, Beckers A, Veyrac M, Proye C, Ruszniewski P, Mignon M (1999) Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Neoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE). Gastroenterology 116: 286-293.
21. Mignon M, Cadiot G (1998) Diagnostic and therapeutic criteria in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. J Intern Med 243: 489-494.
22. Norton JA, Fraker DL, Alexander HR, Venzon DJ, Doppman JL, Serrano J, Goebel SU, Peghini PL, Roy PK, Gibril F, Jensen RT (1999) Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 341: 635-644.
23. Triponez F, Dosseh D, Goudet P, Cougard P, Bauters C, Murat A, Cadiot G, Niccoli-Sire P, Chayvialle JA, Calender A, Proye CA (2006) Epidemiology data on 108 MEN 1 patients from the GTE with isolated non-functioning tumors of the pancreas. Ann Surg 243: 265-272.
24. Mutch MG, Frisella MM, DeBenedetti MK, Doherty GM, Norton JA, Wells SA Jr, Lairmore TC (1997) Pancreatic polypeptide is a useful plasma marker for radiographically evident pancreatic islet cell tumors in patients with multiple endocrine neoplasia type 1. Surgery 122: 1012-1019.
25. Triponez F, Goudet P, Dosseh D, Cougard P, Bauters C, Murat A, Cadiot G, Niccoli-Sire P, Calender A, Proye CA; French Endocrine Tumor Study Group (2006) Is surgery beneficial for MEN1 patients with small (
26. Lowney JK, Frisella MM, Lairmore TC, Doherty GM (1998) Pancreatic islet cell tumor metastasis in multiple endocrine neoplasia type 1: correlation with primary tumor size. Surgery 124: 1043-1048.
27. Thompson NW (1998) Management of pancreatic endocrine tumors in patients with multiple endocrine neoplasia type 1. Surg Oncol Clin North Am 7: 881-891.
28. Skogseid B, Oberg K, Eriksson B, Juhlin C, Granberg D, Akerstrom G, Rastad J (1996) Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I. World J Surg 20: 872-876.
29. Bartsch DK, Fendrich V, Langer P, Celik I, Kann PH, Rothmund M (2005) Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Ann Surg 242: 757-764.
30. Kouvaraki MA, Shapiro SE, Cote GJ, Lee JE, Yao JC, Waguespack SG, Gagel RF, Evans DB, Perrier ND (2006) Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World J Surg 30: 643-653.
31. Akerstrom PG, Hellman P, Skogseid B (2005) Pancreatic tumours as part of the MEN-I syndrome. Best Pract Res Clin Gastroenterol 19: 819-830.
32. Lillemoe KD, Kaushal S, Cameron JL, Sohn TA, Pitt HA, Yeo CJ (1999) Distal pancreatectomy: indications and outcomes in 235 patients. Ann Surg 229: 693-698.
33. Slezak LA, Andersen DK (2001) Pancreatic resection: effects on glucose metabolism. World J Surg 25: 452-460.
34. McCallum RW, Parameswaran V, Burgess JR (2006) Multiple endocrine neoplasia type 1 (MEN1) is associated with an increased prevalence of diabetes mellitus and impaired fasting glucose. Clin Endocrinol 65: 163-168.
35. Torrens JI, Skurnick J, Davidow AL, Korenman SG, Santoro N, Soto-Greene M, Lasser N, Weiss G; Study of Women's Health Across the Nation (SWAN) (2004) Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women's Health Across the Nation (SWAN). Diabetes Care 27: 354-361.
36. Fukushima M, Usami M, Ikeda M, Nakai Y, Taniguchi A, Matsuura T, Suzuki H, Kurose T, Yamada Y, Seino Y (2004) Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes. Metabolism 53: 831-835.
37. Shibata S, Sato T, Andoh H, Yasui O, Yoshioka M, Kurokawa T, Watanabe G, Ise N, Kotanagi H, Asanuma Y, Koyama K (2004) Outcomes and indications of segmental pancreatectomy. Comparison with distal pancreatectomy. Dig Surg 21: 48-53.
38. Lee BW, Kang HW, Heo JS, Choi SH, Kim SY, Min YK, Chung JH, Lee MK, Lee MS, Kim KW (2006) Insulin secretory defect plays a major role in the development of diabetes in patients with distal pancreatectomy. Metabolism 55: 135-141.